Abstract
Deep brain stimulation (DBS) is an approved treatment for neurological diseases and a promising one for psychiatric conditions, which may produce spectacular results very quickly. It is also a powerful tool for brain research and exploration. Beyond an overview of the ethical and legal literature on this topic, this paper aims at showing that DBS is a compelling example for ethical-legal reflection, as it combines a highly technical surgical procedure, a complex active medical device and neuromodulation of the human brain to restore lost abilities caused by a chronic and evolving disease. Some of the ethical and legal issues raised by DBS are not specific, but shed new light on medical ethics and law. Others are more DBS-specific, as they are linked to the intricacies of research and treatment, to the need to tune the device, to the patients’ control over the device and its effects and to the involvement of family caregivers.
Similar content being viewed by others
References
Agid, Y., M. Schüpbach, M. Gargiulo, L. Mallet, J.L. Houeto, et al. 2006. Neurosurgery in Parkinson’s disease: The doctor is happy, the patient less so? Journal of Neural Transmission 70: 409–414.
Amadio, J.P., and N.M. Boulis. 2011. Practical considerations in the ethics of parkinsonian deep brain stimulation. AJOB Neuroscience 2: 24–26.
Bell, E., G. Mathieu, and E. Racine. 2009. Preparing the ethical future of deep brain stimulation. Surgical Neurology 72: 577–586.
Bell, E., B. Maxwell, M.O. McAndrews, A. Sadikot, and E. Racine. 2011a. Deep brain stimulation and ethics: Perspectives from a multisite qualitative study of canadian neurosurgical centers. World Neurosurgery 76 (6): 537–547.
Bell, E., B. Maxwell, Pat McAndrews, A. Sadikot, and E. Racine. 2011b. A review of social and relational aspects of deep brain stimulation in Parkinson’s disease informed by healthcare. Parkinson’s Disease. https://doi.org/10.4061/2011/871874.
Benabid, A.L. 2003. Deep brain stimulation for Parkinson’s disease. Current Opinion in Neurobiology 13: 696–706.
Benabid, A.L. 2017. Les traitements de la maladie de Parkinson. Les Dîners de l’Institut Diderot, 12 juin 2017. Paris: Publications de l’Institut Diderot.
Berryessa, C.M., J.A. Chandler, and P. Reiner. 2016. Public attitudes toward legally coerced biological treatments of criminals. Journal of Law and the Biosciences 3 (3): 447–467.
Blank, Robert H. 2013. Intervention in the Brain. Politics, policy, and ethics. Cambridge: MIT Press.
Burkhard, P.R., C. Lüscher, S. Catalano-Chiuvé, A. Gronchi-Perrin, F. Vingerhoets, et al. 2008. Troubles du contrôle des impulsions et maladie de Parkinson. Revue Médicale Suisse 4: 1145–1150.
Cabrera, L.Y., E.L. Evans, and R.H. Hamilton. 2014. Ethics of the electrified mind: Defining issues and perspectives on the principled use of brain stimulation in medical research and clinical care. Brain Topography 27 (1): 33–45.
Charles, D., P.E. Konrad, J.S. Neimat, A.L. Molinari, M.G. Tramontana, et al. 2014. Subthalamic nucleus deep brain stimulation in early stage Parkinson’s disease. Parkinsonism and Related Disorders 20: 731–737.
Cherici, C., and J.C. Dupont (eds.). 2008. Les querelles du cerveau. Comment furent inventées les neurosciences. Paris: Vuibert.
Christopher, P.P., and L. Dunn. 2015. Risk and consent in neuropsychiatric deep brain stimulation: An exemplary analysis of treatment-resistant depression, obsessive-compulsive disorder, and dementia. In Handbook of neuroethics, vol. 2, ed. J. Clausen and N. Levy, 589–605. Dordrecht: Springer.
Cif, L., and P. Coubes. 2016. Historical developments in children's deep brain stimulation. European Journal of Paediatric Neurology. https://doi.org/10.1016/j.ejpn.2016.08.010.
Clausen, J. 2010. Ethical brain stimulation: Neuroethics of deep brain stimulation in research and clinical practice. European Journal of Neuroscience 32: 1152–1162.
Comité Consultatif National d’Éthique pour les Sciences de la Vie et de la Santé. 2002. Avis n° 71: La neurochirurgie fonctionnelle d’affections psychiatriques sévères. 2002 : https://www.ccne-ethique.fr/fr/publications/avis-sur-la-neurochirurgie-fonctionnelle-daffections-psychiatriques-severes#.WftPn2jWw2w. Accessed 12 Dec 2018.
Comité Consultatif National d’Éthique pour les Sciences de la Vie et de la Santé. 2013. Avis n°122. Recours aux techniques biomédicales en vue de ‟neuro-amélioration” chez la personne non malade : Enjeux éthiques, Paris : 12 Décembre 2013.
Davidson, B., L.M. Elkaim, N. Lipsman, and G.M. Ibrahim. 2018. An ethical framework for deep brain stimulation in children. Neurosurgery Focus 45 (3): E11.
Dekkers, W., and G. Boer. 2001. Sham neurosurgery in patients with Parkinson’s disease: Is it morally acceptable? Journal of Medical Ethics 27: 151–156.
Desmoulin-Canselier, S. 2018a. Patient’s lived experience between medical research and care. Medicine, Health Care and Philosophy. https://doi.org/10.1007/s11019-018-9859-5.
Desmoulin-Canselier, S. 2018b. Etude neurosciences. Dictionnaire permanent santé, bioéthique et biotechnologies. Paris: Editions Législatives.
Deuschl, G., and Y. Agid. 2013. Subthalamic neurostimulation for Parkinson’s disease with early fluctuations: Balancing the risks and benefits. The Lancet Neurology 12 (2013): 1025–1034.
DiFrancesco, M.F., C.H. Halpern, H.H. Hurtig, G.H. Baltuch, and G.G. Heuer. 1701e. Pediatric indications for deep brain stimulation. Child's Nervous System 28 (10): 1701e14.
Doruk Camsari, D., M. Kirkovski, and P.E. Croarkin. 2018. Therapeutic applications of invasive neuromodulation in children and adolescents. Psychiatric Clinics of North America. https://doi.org/10.1016/j.psc.2018.04.008.
Dos Santos, J.F.A., S.T. du Montcel, M. Gargiulo, C. Behar, S. Montel, et al. 2017. Tackling psychosocial maladjustment in Parkinson’s disease patients following subthalamic deep-brain stimulation: A randomised clinical trial. PLoS ONE 12 (4): e0174512.
Dos Santos, J.F.A., P. Krack, S.M. Momjian, G. Bondolfi, and L. Mallet. 2018. Trouble obsessionnel compulsif et stimulation cérébrale profonde un futur si proche. Revue Médicale Suisse 14 (593): 327–330.
Fins, J.J. 2012. Deep Brain Stimulation as a probative biology: Scientific inquiry and the mosaic device. American Journal of Bioethics-Neuro Science 3 (1): 4–8.
Fins, J.J., C.S. Kubu, H.S. Mayberg, R. Merkel, B. Nuttin, et al. 2017. Being open minded about neuromodulation trials: Finding success in our “failures”. Brain Stimulation 10 (2): 181–186.
Fins, J.J., and Z.E. Shapiro. 2014. Deep brain stimulation, brain maps and personalized medicine: Lessons from the human genome project. Brain Topography 27: 55–62.
Focquaert, F. 2011. Deep brain stimulation in children: Parental authority versus shared decision-making. Neuroethics. https://doi.org/10.1007/s12152-011-9098-4.
Foley, P. 2015. Deep brain stimulation for Parkinson’s disease: Historical and neuroethical aspects. In Handbook of neuroethics, vol. 2, ed. J. Clausen and N. Levy, 561–587. Dordrecht: Springer.
Frank, M.J., J. Samanta, A.A. Moustafa, and S.J. Sherman. 2007. Hold your horses: Impulsivity, deep brain stimulation, and medication in Parkinsonism. Science 318 (5854): 1309–1312.
Fumagalli, M., and A. Priori. 2012. Functional and clinical neuroanatomy of morality. Brain 135: 2006–2021.
Gardner, J. 2013. A history of deep brain stimulation: Technological innovation and the role of clinical assessment tools. Social Studies of Science 43 (5): 707–728.
Gardner, J. 2017. Patient-centred medicine and the broad clinical gaze: Measuring outcomes in paediatric deep brain stimulation. BioSocieties 12 (2): 239–256. https://doi.org/10.1057/biosoc.2016.6
Gardner, J., and C. Williams. 2015. Responsible research and innovation: A manifesto for empirical ethics? Clinical Ethics 10 (1–2): 5–12.
Goering, S., E. Klein, D. Dougherty, and A. Widge. 2017. Staying in the loop: Relational agency and identity in next-generation DBS for psychiatry. AJOB Neuroscience 8: 2. https://doi.org/10.1080/21507740.2017.1320320.
Gilbert, F. 2012. The burden of normality: from ‘chronically ill’ to ‘symptom free’. New ethical challenges for deep brain stimulation postoperative treatment. Journal of Medical Ethics 38 (7): 408–412.
Gilbert, F. 2015. Self-estrangement and deep brain stimulation: Ethical issues related to forced explantation. Neuroethics 8 (2): 107–114. https://doi.org/10.1007/s12152-014-9224-1.
Gilbert, F., et al. 2018. Deflating the “DBS causes personality changes” bubble. Neuroethics. https://doi.org/10.1007/s12152-018-9373-8.
Gimeno, H., K. Tustin, R. Selway, and J.P. Lin. 2012. Beyond the Burke–Fahn–Marsden Dystonia rating scale: Deep brain stimulation in childhood secondary dystonia. European Journal of Paediatric Neurology 16 (5): 501–508. https://doi.org/10.1016/j.ejpn.2011.12.014.
Glannon, W. 2009. Stimulating brains, altering minds. Journal of Medical Ethics 35: 289–292.
Greenberg, B.D., and A.R. Rezai. 2003. Mechanisms and the current state of deep brain stimulation in neuropsychiatry. CNS Spectrums 8 (7): 522–526.
Gunduz, A., K.D. Foote, and M.S. Okun. 2017. Reengineering deep brain stimulation for movement disorders: Emerging technologies. Current Opinion in Biomedical Engineering 4: 97–105.
Hacker, M.L., J. Tonascia, M. Turchan, A. Currie, L. Heusinkveld, et al. 2015. Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson’s disease. Parkinsonism and Related Disorders 21 (10): 1177–1183.
Hale, A.T., M.A. Monsour, J.D. Rolston, R.P. Naftel, and D.J. Englot. 2018. Deep brain stimulation in pediatric dystonia: A systematic review. Neurosurgical Review. https://doi.org/10.1007/s10143-018-1047-9.
Hariz, M. 2012. Twenty-five years of deep brain stimulation: Celebrations and apprehensions. Movement Disorders 27 (7): 930–933.
Hariz, M. 2013. Early surgery for Parkinson’s disease? Maybe, but not just yet. The Lancet Neurology 12: 938–939.
Hariz, M. 2014. Deep brain stimulation: New techniques. Parkinsonism and Related Disorders 20 (S1): 192–196.
Hariz, M. 2015. There is no credible rational for deep brain stimulation in very early Parkinson’s disease! Parkinsonism and Related Disorders 21: 345–346.
Hartmann, C.J., S. Fliegen, S.J. Groiss, L. Wojtecki, and A. Schnitzler. 2019. An update on best practice of deep brain stimulation in Parkinson's disease. Therapeutic Advances in Neurological Disorders 12: 1756286419838096. https://doi.org/10.1177/1756286419838096.
Haute autorité de Santé- Commission nationale d’évaluation des dispositifs médicaux et des technologies de santé (CNEDiMTS). 2017. Avis du 11 juillet 2017 : Conclusions sur le VERCISE GEVIA, système rechargeable pour stimulation cérébrale profonde : https://www.has-sante.fr/portail/upload/docs/evamed/CEPP-5364_VERCISE%20GEVIA%205364_occultations.pdf. Accessed 12 Oct 2018.
Heiden, P., A. Heinz, and N. Romanczuk-Seiferth. 2017. Pathological gambling in Parkinson’s disease: What are the risk factors and what is the role of impulsivity? European Journal of Neuroscience 45: 62–72.
Holtzheimer, P.E., et al. 2017. Subcallosal cingulate DBS for TRD: A multisite, randomised, sham-controlled trial. The Lancet Psychiatry 4 (11): 839–849.
Horng, S., and F.G. Miller. 2015. Ethics of sham surgery in clinical trials for neurologic disease. In Handbook of neuroethics, vol. 2, ed. J. Clausen and N. Levy, 1125–1138. Dordrecht: Springer.
Klaming, L., and P. Haselager. 2013. Did my brain implant make me do it? Questions raised by DBS regarding psychological continuity, responsibility for action and mental competence. Neuroethics 6 (3): 527–539.
Klein, E. 2015. Models of the patient-machine-clinician relationship in closed-loop machine neuromodulation. In Machine medical ethics, ed. S.P. van Rysewyk and M. Pontier, 273–290. New York: Springer.
Lahtinen, M. 2016. A child is not a small adult: Complications in deep brain stimulation in children Surgical safety and complications of deep brain stimulation for childhood dystonia. European Journal of Paediatric Neurology. https://doi.org/10.1016/j.ejpn.2016.12.001.
Lévêque, M. 2013. Psychochirurgie. Paris: Springer.
Lewis, C.J., F. Maier, C. Eggers, E.A. Pelzer, M. Maarouf, et al. 2014. Parkinson’s disease patients with subthalamic stimulation and carers judge quality of life differently. Parkinsonism and Related Disorders 20 (5): 514–519.
Leykin, Y., P.P. Christopher, P.E. Holtzheimer, P.S. Appelbaum, H.S. Mayberg, et al. 2011. Participants’ perceptions of deep brain stimulation research for treatment-resistant depression: Risks, benefits, and therapeutic misconception. AJOB Primary Research. 2: 33–41.
Lhommée, E., H. Klinger, S. Thobois, E. Schmitt, C. Ardouin, et al. 2012. Subthalamic stimulation in Parkinson’s disease: Restoring the balance of motivated behaviours. Brain 135 (Pt 5): 1463–1477.
Lipsman, N., D. Mendelsohn, T. Taira, and M. Bernstein. 2011. The contemporary practice of psychiatric surgery: Results from a survey of North American functional neurosurgeons. Stereotactic and Functional Neurosurgery 89 (2): 103–110.
Mallet, L., M. Polosan, N. Jaafari, N. Baup, M.L. Welter, et al. 2008. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. New England Journal of Medicine 359 (20): 2121–2134.
Mayberg, H.S., A.M. Lozano, V. Voon, H.E. McNeely, D. Seminowicz, et al. 2005. Deep brain stimulation for treatment-resistant depression. Neuron 45 (5): 651–660.
Mestre, T.A., A.J. Espay, C. Marras, M.H. Eckman, P. Pollak, et al. 2014. Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson’s disease: The EARLYSTIM trial: Early is not always better. Movement Disorders 29 (14): 1751–1756.
Modolo, J., B. Bhattacharya, R. Edwards, J. Campagnaud, A. Legros, et al. 2010. Using a virtual cortical module implementing a neural field model to modulate brain rhythms in Parkinson’s disease. Frontiers in Neuroscience 4: 45.
Modolo, J., A. Legros, and A. Beuter. 2014. The next move in neuromodulation therapy: a question of timing. Frontiers in Computional Neuroscience 8: 162.
Morgante, L., et al. 2007. How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. Parkinsonism and Related Disorders 13 (8): 528–531.
Moutaud, B. 2009. C’est un problème neurologique ou psychiatrique? Ethnologie de la stimulation cérébrale profonde appliquée au trouble obsessionnel compulsif (thèse), 1–499. Paris: Université Paris Descartes.
Moutaud, B. 2016. Neuromodulation technologies and the regulation of forms of life: Exploring, treating. Enhancing. Medical Anthropology 35: 90–130.
Mundale, J. 2016. Reversibility and deep brain stimulation. Journal of Cognition and Neuroethics 3 (4): 97–111.
Nijensohn, D.E., and Dagi T. Forcht. 2018. Neurosurgical intervention for treatment-resistant psychiatric disorders. In Treatment resistance in psychiatry risk factors, biology, and management, ed. Y.-K. Kim, 377–403. New York: Springer.
Pateraki, M. 2018. Τhe multiple temporalities of deep brain stimulation (DBS) in Greece. Medicine, Health Care and Philosophy. https://doi.org/10.1007/s11019-018-9861-y.
Pugh, J. 2019. No going back? Reversibility and why it matters for deep brain stimulation. Journal of Medical Ethics. https://doi.org/10.1136/medethics-2018-105139.
Pugh, J., L. Pycroft, A. Sandberg, T. Aziz, and J. Savulescu. 2018. Brainjacking in deep brain stimulation and autonomy. Ethics Information Technology. 20 (3): 219–232.
Rachet-Darfeuille, V. 2019. L’appréciation de la faute médicale technique par le juge administratif: La stimulation cérébrale profonde est-elle un cas ? In La stimulation cérébrale profonde de l’innovation au soin, ed. S. Desmoulin-Canselier, M. Gaille, and B. Moutaud, 267–280. New York: Hermann.
Ramasubbu, R., S. Lang, and Z.H.T. Kiss. 2018. Dosing of electrical parameters in deep brain stimulation (DBS) for intractable depression: A review of clinical studies. Frontier Psychiatry. https://doi.org/10.3389/fpsyt.2018.00302.
Rosin, B., M. Slovik, R. Mitelman, M. Rivlin-Etzion, S. Haber, et al. 2011. Closed-loop deep brain stimulation is superior in ameliorating parkinsonism. Neuron 72 (2): 370–384.
Schlaepfer, T.E., and J.J. Fins. 2010. Deep brain stimulation and the neuroethics of responsible publishing: When one is not enough. Journal of the American Medical Association 303 (8): 775–776.
Schuepbach, W.M., et al. 2013. Neurostimulation for Parkinson’s disease with early motor complications. New England Journal of Medicine 368: 610–622. https://doi.org/10.1056/NEJMoa1205158.
Schüpbach, M., M. Gargiulo, M.L. Welter, L. Mallet, C. Béhar, et al. 2006. Neurosurgery in Parkinson disease: A distressed mind in a repaired body? Neurology 66 (12): 1811–1816.
Schüpbach, M., J. Rau, J.L. Houeto, P. Krack, A. Schnitzler, et al. 2014. Myths and facts about the EARLYSTIM study. Movement Disorders 29 (14): 1742–1750.
Smeding, H.M.M., A.E. Goudriaan, E.M.J. Foncke, P.R. Schuurman, J.D. Speelman, et al. 2007. Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. Journal of Neurology, Neurosurgery and Psychiatry 78 (5): 517–519.
Strauss, I., S. Kalia, and A. Lozano. 2014. Where are we with surgical therapies for Parkinson’s disease. Parkinsonism and Related Disorders 20 (S1): 187–191.
Synofzik, M. 2013. Functional neurosurgery and deep brain stimulation. In Neuroethics in practice medicine, mind, and society, ed. A. Chatterjee and M.J. Farah Neuroethics, 189–208. New-York: Oxford University Press.
Thouvenin, D. 2009. Commentaire de l’article L. 1121-1 du code de la santé publique. In Code de la santé publique commenté, ed. F. Dreifuss-Netter, 43–55. Paris: Litec.
Thouvenin, D. 2012. La loi n° 2012-300 du 5 mars 2012: Des recherches pratiquées sur la personne aux recherches avec la personne. Revue de Droit Sanitaire et Social 5: 787–799.
Underwood, E. 2015. Brain implant trials raise ethical concerns. Science 348 (6240): 1186–1187.
Unterrainer, M., and F.S. Oduncu. 2015. The ethics of deep brain stimulation. Medicine Health Care and Philosophy 18: 475–485.
Viana, J.N.M., et al. 2017. Currents of memory: Recent progress, translational challenges, and ethical considerations in fornix deep brain stimulation trials for Alzheimer's disease. Neurobiology of Aging 56: 202–210. https://doi.org/10.1016/j.neurobiolaging.2017.03.001.
Voon, V., P. Krack, A. Lang, A.M. Lozano, K. Dujardin, et al. 2008. Multicentre study on suicide outcomes following subthalamic stimulation for Parkinson’s disease. Brain 131 (Pt 10): 2720–2728.
Voon, V., M. Sohr, A.E. Lang, M.N. Potenza, A.D. Siderowf, et al. 2011. Impulse control disorders in parkinson disease: A multicenter case–control study. Annals of Neurology 69 (6): 986–996.
Weintraub, D., J. Koester, M.N. Potenza, A.D. Siderowf, M. Stacy, et al. 2010. Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Archives of Neurology 67 (5): 589–595.
Witt, K., J. Kuhn, L. Timmermann, M. Zurowski, and C. Woopen. 2013. Deep brain stimulation and the search for identity. Neuroethics 6 (3): 499–511.
Wolf, M.E., M. Abdallat, C. Blahak, and J.K. Krauss. 2017. Pathological crying induced by deep brain stimulation of the subthalamic nucleus in Parkinson’s disease. Journal Clinical Neuroscience 45: 159–161.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author hereby states that there is no conflict of interest regarding this paper.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Desmoulin-Canselier, S. DBS: a compelling example for ethical and legal reflection—a French perspective on ethical and legal concerns about DBS. Monash Bioeth. Rev. 38, 15–34 (2020). https://doi.org/10.1007/s40592-020-00111-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40592-020-00111-3